169 related articles for article (PubMed ID: 24211167)
1. Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation.
Dakshinamoorthy G; Kalyanasundaram R
Vaccine; 2013 Dec; 32(1):19-25. PubMed ID: 24211167
[TBL] [Abstract][Full Text] [Related]
2. Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primates.
Khatri V; Chauhan N; Vishnoi K; von Gegerfelt A; Gittens C; Kalyanasundaram R
Int J Parasitol; 2018 Aug; 48(9-10):773-783. PubMed ID: 29885437
[TBL] [Abstract][Full Text] [Related]
3. Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis.
Chauhan N; Banerjee P; Khatri VK; Canciamille A; Gilles J; Kalyanasundaram R
Parasitol Res; 2017 Oct; 116(10):2821-2830. PubMed ID: 28828575
[TBL] [Abstract][Full Text] [Related]
4. Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis.
Dakshinamoorthy G; Munirathinam G; Stoicescu K; Reddy MV; Kalyanasundaram R
PLoS One; 2013; 8(10):e77394. PubMed ID: 24146990
[TBL] [Abstract][Full Text] [Related]
5. Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis.
Joseph SK; Ramaswamy K
Vaccine; 2013 Jul; 31(33):3320-6. PubMed ID: 23735679
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a multivalent vaccine against lymphatic filariasis in rhesus macaque model.
Dakshinamoorthy G; von Gegerfelt A; Andersen H; Lewis M; Kalyanasundaram R
PLoS One; 2014; 9(11):e112982. PubMed ID: 25401783
[TBL] [Abstract][Full Text] [Related]
7. Multivalent fusion protein vaccine for lymphatic filariasis.
Dakshinamoorthy G; Samykutty AK; Munirathinam G; Reddy MV; Kalyanasundaram R
Vaccine; 2013 Mar; 31(12):1616-22. PubMed ID: 23036503
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis.
Veerapathran A; Dakshinamoorthy G; Gnanasekar M; Reddy MV; Kalyanasundaram R
PLoS Negl Trop Dis; 2009 Jun; 3(6):e457. PubMed ID: 19513102
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic filariasis.
Dakshinamoorthy G; Samykutty AK; Munirathinam G; Shinde GB; Nutman T; Reddy MV; Kalyanasundaram R
PLoS One; 2012; 7(4):e34077. PubMed ID: 22496777
[TBL] [Abstract][Full Text] [Related]
10. Immunoadjuvant effect of diethylcarbamazine in experimental filariasis.
Parasurama Jawaharlal JP; Rajaiah Prabhu P; Gandhirajan A; Krishnan N; Perumal K
Int Immunopharmacol; 2015 Feb; 24(2):458-462. PubMed ID: 25576657
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of immune response elicited by inulin as an adjuvant with filarial antigens in mice model.
Mahalakshmi N; Aparnaa R; Kaliraj P
Scand J Immunol; 2014 Oct; 80(4):261-70. PubMed ID: 25041426
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of Brugia malayi Abundant Larval Transcript-2, a potential filarial vaccine candidate expressed in tobacco.
Ganapathy M; Perumal A; Mohan C; Palaniswamy H; Perumal K
Plant Cell Rep; 2014 Jan; 33(1):179-88. PubMed ID: 24277081
[TBL] [Abstract][Full Text] [Related]
13. Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis.
Anugraha G; Jeyaprita PJ; Madhumathi J; Sheeba T; Kaliraj P
Acta Parasitol; 2013 Dec; 58(4):468-77. PubMed ID: 24338307
[TBL] [Abstract][Full Text] [Related]
14. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.
Gregory WF; Atmadja AK; Allen JE; Maizels RM
Infect Immun; 2000 Jul; 68(7):4174-9. PubMed ID: 10858234
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.
Vanam U; Pandey V; Prabhu PR; Dakshinamurthy G; Reddy MV; Kaliraj P
Am J Trop Med Hyg; 2009 Feb; 80(2):319-24. PubMed ID: 19190232
[TBL] [Abstract][Full Text] [Related]
16. A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds.
Anand SB; Kodumudi KN; Reddy MV; Kaliraj P
J Helminthol; 2011 Dec; 85(4):442-52. PubMed ID: 21208482
[TBL] [Abstract][Full Text] [Related]
17. Immunoprophylactic evaluation of a 37-kDa Brugia malayi recombinant antigen in lymphatic filariasis.
Dabir P; Dabir S; Krithika KN; Goswami K; Reddy MV
Clin Microbiol Infect; 2006 Apr; 12(4):361-8. PubMed ID: 16524413
[TBL] [Abstract][Full Text] [Related]
18. Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.
Thirugnanam S; Pandiaraja P; Ramaswamy K; Murugan V; Gnanasekar M; Nandakumar K; Reddy MV; Kaliraj P
Exp Parasitol; 2007 Aug; 116(4):483-91. PubMed ID: 17442307
[TBL] [Abstract][Full Text] [Related]
19. Ligand binding properties of two Brugia malayi fatty acid and retinol (FAR) binding proteins and their vaccine efficacies against challenge infection in gerbils.
Zhan B; Arumugam S; Kennedy MW; Tricoche N; Lian LY; Asojo OA; Bennuru S; Bottazzi ME; Hotez PJ; Lustigman S; Klei TR
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006772. PubMed ID: 30296268
[TBL] [Abstract][Full Text] [Related]
20. Immunoprophylactic potential of a 120 kDa Brugia malayi adult antigen fraction, BmA-2, in lymphatic filariasis.
Chenthamarakshan V; Reddy MV; Harinath BC
Parasite Immunol; 1995 Jun; 17(6):277-85. PubMed ID: 7494640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
